Catalog No.
PHE58001
Species reactivity
Human, Mouse, Rat
Host species
Rabbit
Isotype
IgG
Clonality
Polyclonal
Immunogen
E. coli - derived recombinant Human LSS (Asp388-Pro549).
Tested applications
ELISA: 1:4000-1:8000, IHC: 1:50-1:100, WB: 1:1000-1:4000
Target
OSC,Lanosterol synthase,hOSC,Oxidosqualene--lanosterol cyclase,2,3-epoxysqualene--lanosterol cyclase,LSS
Purification
Purified by antigen affinity column.
Accession
P48449
Applications
ELISA, IHC, WB
Form
Liquid
Storage buffer
0.01M PBS, pH 7.4, 50% Glycerol, 0.05% Proclin 300.
Stability and Storage
Use a manual defrost freezer and avoid repeated freeze thaw cycles. Store at 2 to 8°C for frequent use. Store at -20 to -80°C for twelve months from the date of receipt.
Risk and prognosis of second primary malignancies in patients with follicular lymphoma in the era of rituximab: A population study based on the SEER database., PMID:40435210
A modular mRNA vaccine platform encoding antigen-presenting capsid virus-like particles enhances the immunogenicity of the malaria antigen Pfs25., PMID:40369344
Preclinical B cell depletion and safety profile of a brain-shuttled crystallizable fragment-silenced CD20 antibody., PMID:40118783
Plain Language Summary of Publication: Design of the Phase 3 AZALEA Trial of Nipocalimab in Severe Hemolytic Disease of the Fetus and Newborn., PMID:40049596
YabXnization platform: A monoclonal antibody heterologization server based on rational design and artificial intelligence-assisted computation., PMID:39660217
The factor XI/XIa antibody abelacimab combined with enoxaparin inhibits filter clotting in hemodialysis circuits ex vivo., PMID:39549166
The Escherichia coli TolC efflux pump protein is immunogenic and elicits protective antibodies., PMID:39278634
Evaluation of the effects of the Zika Virus-Immunoglobulin G+ complex on murine microglial cells., PMID:38935226
Real-life effectiveness of dupilumab in chronic rhinosinusitis with nasal polyps. Results from eight Hungarian centres with 12-month follow-up., PMID:38848046
Tinostamustine (EDO-S101), an Alkylating Deacetylase Inhibitor, Enhances the Efficacy of Daratumumab in Multiple Myeloma by Upregulation of CD38 and NKG2D Ligands., PMID:38731936
IL-1β Inhibition Partially Negates the Beneficial Effects of Diet-Induced Atherosclerosis Regression in Mice., PMID:38695167
A dual-targeting therapeutic nanobubble for imaging-guided atherosclerosis treatment., PMID:38586870
Gamma protocadherins in vascular endothelial cells inhibit Klf2/4 to promote atherosclerosis., PMID:38293157
ProtT5 and random forests-based viscosity prediction method for therapeutic mAbs., PMID:38246432
Guillain-Barré Syndrome Mimicking Lumbar Spinal Stenosis with Segmental Weakness in L5-S1 Myotomes., PMID:37981299
The distribution pattern of nerve enlargement in clinical subtypes of chronic inflammatory demyelinating polyneuropathy., PMID:37823703
Antibody-mediated neutralization of galectin-3 as a strategy for the treatment of systemic sclerosis., PMID:37652913
Low-risk HPLLs/ABC score patients with splenic marginal zone lymphoma can be safely managed without treatment: Results from a prospective Spanish study., PMID:37386877
Clinical utility of an antibody-free LC-MS method to detect brain amyloid deposition in cognitively unimpaired individuals from the screening visit of the A4 Study., PMID:37274930
Omicron BQ.1.1 and XBB.1 unprecedentedly escape broadly neutralizing antibodies elicited by prototype vaccination., PMID:37219999
Tumour associated vasculature-on-a-chip for the evaluation of microbubble-mediated delivery of targeted liposomes., PMID:36779251
Licensed liposomal vaccines and adjuvants in the antigen delivery system., PMID:36685697
Hydration in Deep Eutectic Solvents Induces Non-monotonic Changes in the Conformation and Stability of Proteins., PMID:36524921
SARS-CoV-2 mRNA-vaccine candidate; COReNAPCIN®, induces robust humoral and cellular immunity in mice and non-human primates., PMID:36056015
Third COVID-19 vaccine dose boosts neutralizing antibodies in poor responders., PMID:35832309
Maternal Tetanus Toxoid, Reduced Diphtheria Toxoid, and Acellular Pertussis Vaccination During Pregnancy: Impact on Infant Anti-Pertussis Antibody Concentrations by Maternal Pertussis Priming Series., PMID:35642525
The Current Landscape of Prevention Trials in Dementia., PMID:35587314
Structure, Immunogenicity, and IgE Cross-Reactivity among Walnut and Peanut Vicilin-Buried Peptides., PMID:35139305
Identification of Risk Factors for Dupilumab-associated Ocular Surface Disease in Patients with Atopic Dermatitis., PMID:35098318
Quantitative CT analysis of interstitial pneumonia in anti-melanoma differentiation-associated gene 5 antibody-positive dermatomyositis: a single center, retrospective study., PMID:35034225
Neoadjuvant immunotherapy with nivolumab and ipilimumab induces major pathological responses in patients with head and neck squamous cell carcinoma., PMID:34937871
In silico evaluation of limited sampling strategies for individualized dosing of extended half-life factor IX concentrates in hemophilia B patients., PMID:34651201
Outcomes of cardiac diffuse large B-cell lymphoma (DLBCL) in the rituximab era., PMID:34324949
Atypical chronic inflammatory demyelinating polyradiculoneuropathy: recent advances on classification, diagnosis, and pathogenesis., PMID:34267052
Design and proof of concept for targeted phage-based COVID-19 vaccination strategies with a streamlined cold-free supply chain., PMID:34234013
Durvalumab with olaparib and paclitaxel for high-risk HER2-negative stage II/III breast cancer: Results from the adaptively randomized I-SPY2 trial., PMID:34143979
Multisystem Inflammatory Syndrome in Children - Initial Therapy and Outcomes., PMID:34133855
The need to show minimum clinically important differences in Alzheimer's disease trials., PMID:34087114
A SARS-CoV-2 neutralizing antibody with extensive Spike binding coverage and modified for optimal therapeutic outcomes., PMID:33976198
Bevacizumab, carboplatin, and paclitaxel in the first line treatment of advanced ovarian cancer patients: the phase IV MITO-16A/MaNGO-OV2A study., PMID:33931498
Identification of Very Low-Risk Subgroups of Patients with Primary Mediastinal Large B-Cell Lymphoma Treated with R-CHOP., PMID:33870594
Prognostic significance of bone marrow 2-[18F]-fluoro-2-deoxy-d-glucose uptake in diffuse large B-cell lymphoma: relation to iliac crest biopsy results., PMID:33762136
SARS-CoV-2 neutralizing human recombinant antibodies selected from pre-pandemic healthy donors binding at RBD-ACE2 interface., PMID:33707427
Impact of both socioeconomic level and occupation on antibody prevalence to SARS-CoV-2 in an Egyptian cohort: The first episode., PMID:33547814
Prior activation state shapes the microglia response to antihuman TREM2 in a mouse model of Alzheimer's disease., PMID:33446504
Development and Preliminary Clinical Activity of PD-1-Guided CTLA-4 Blocking Bispecific DART Molecule., PMID:33377134
Newcastle disease virus (NDV) expressing the spike protein of SARS-CoV-2 as a live virus vaccine candidate., PMID:33232870
A phase I, randomized, single-dose pharmacokinetic study comparing sb8 (bevacizumab biosimilar) with reference bevacizumab in healthy volunteers., PMID:32949267
Multisystem Inflammatory Syndrome in U.S. Children and Adolescents., PMID:32598831
Evaluating the Therapeutic Efficacy of Mono- and Bivalent Affibody-Based Fusion Proteins Targeting HER3 in a Pancreatic Cancer Xenograft Model., PMID:32545760
For research use only. Not for human or drug use.
